Abstract
Subcutaneous (SC) administration of ertapenem in outpatient parenteral antimicrobial therapy (OPAT) services may be a practical alternative to intravenous delivery for complicated infections. The clinical features and outcomes according to route of administration were compared from a large Australian OPAT service. Chronic renal impairment was more common in the SC group, reflecting an opportunity for route of administration as a vein preservation strategy. Adverse events were uncommon and successful outcomes were not different between the groups.
Original language | English |
---|---|
Pages (from-to) | 1717-1721 |
Number of pages | 5 |
Journal | Internal Medicine Journal |
Volume | 51 |
Issue number | 10 |
DOIs | |
Publication status | Published - Oct 2021 |